Paul S. Anderson

from Wikipedia, the free encyclopedia

Paul S. Anderson (* 1938 in Concord , Vermont ) is an American chemist (pharmaceutical chemistry).

Anderson was the son of a teacher and grew up in Swanton , where his father was the school inspector. He studied at the University of Vermont with a bachelor's degree in chemistry in 1959 and was at the 1963 University of New Hampshire at Robert E. Lyle doctorate . As a post-doctoral student he was with Jerrold Meinwald at Cornell University and then went to the research laboratories of Merck , where he became a Research Fellow in the Medicinal Chemistry department in 1969 and was its Executive Director from 1980 to 1988 and became its Vice President for Chemistry West Point Laboratories rose (1988-1994). In 1994 he was Vice President for Physics and Chemistry of the joint venture between Merck and DuPont (DuPont Merck Pharmaceutical Corp.) and after DuPont took over the joint venture in 1998 (as DuPont Pharmaceuticals) he remained Senior Vice President and also during the takeover Bristol-Myers Squibb 2001, as Vice President, Drug Discovery.

In 2003 he received the NAS Award for Chemistry in Service to Society for leading the development of two anti-AIDS drugs at Merck (the HIV protease inhibitor Crixivan and the HIV reverse transcriptase inhibitor Sustiva) and fundamental research on glutamate - Receptor. In 2002 he received the Perkin Medal and in 1995 the EB Herschberg Award from ACS. He has honorary doctorates from the University of Vermont, the University of New Hampshire and the University of Montpellier . In 1997 he was President of the American Chemical Society and in 2006 received the Priestley Medal .

Web links

Individual evidence

  1. biographical data, publications and Academic pedigree of Paul S. Anderson at academictree.org, accessed on January 1, 2018th
  2. biographical data, publications and Academic pedigree of Paul S. Anderson at academictree.org, accessed on January 1, 2018th